{"gao_id": "GAO-23-105947", "published": "2023-01-31T12:00:00Z", "released": "2023-01-31T07:00:00Z", "summary": "In the U.S., pediatric cancer is among the most deadly childhood diseases\u2014but relatively few drugs are approved to treat it. To facilitate the development of safe new drugs to treat children, the RACE Act requires developers of certain adult cancer drugs to submit plans to also study their use in pediatric patients. This has increased the number of planned pediatric cancer studies, but it's too...", "title": "Pediatric Cancer Studies: Early Results of the Research to Accelerate Cures and Equity for Children Act", "topics": ["Clinical trials", "Children", "Drug approvals", "Pediatrics", "Adults", "Health Care", "Health care", "Cancer", "Pediatric drugs", "Orphan drugs", "Drugs"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-23-105947", "versions": [{"title": "Full Report (13 pages)", "url": "https://www.gao.gov/assets/gao-23-105947.pdf"}, {"title": "Accessible PDF (15 pages)", "url": "https://www.gao.gov/assets/820/817227.pdf"}]}